CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-21 | Finley John David CEO, CFO, Director | Grant or award · Common Stock Options | +45,000 | 45,000 | ||
| 2023-11-21 | Neal James R Director | Grant or award · Restricted Stock Units | +5,820 | 5,820 | ||
| 2023-11-21 | Neal James R Director | Grant or award · Common Stock Options | +6,880 | 6,880 | ||
| 2023-11-21 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +5,820 | 5,820 | ||
| 2023-11-21 | GRAY MARY ANN Director | Grant or award · Common Stock Options | +6,880 | 6,880 | ||
| 2023-11-21 | Williams Donald Allen Director | Grant or award · Restricted Stock Units | +5,820 | 5,820 | ||
| 2023-11-21 | Williams Donald Allen Director | Grant or award · Common Stock Options | +6,880 | 6,880 | ||
| 2023-11-21 | Csimma Cristina Director | Grant or award · Restricted Stock Units | +5,820 | 5,820 | ||
| 2023-11-21 | Csimma Cristina Director | Grant or award · Common Stock Options | +6,880 | 6,880 | ||
| 2023-11-21 | Wei Binxian Director | Grant or award · Restricted Stock Units | +5,820 | 5,820 | ||
| 2023-11-21 | Wei Binxian Director | Grant or award · Common Stock Options | +6,880 | 6,880 | ||
| 2023-11-20 | Finley John David CEO, CFO, Director | Grant or award | +10,000 | $0.51 | $5K | 57,781 |
| 2023-11-07 | Jones Mitchell Lawrence Chief Medical Officer | Shares withheld for taxes | −1,630 | $0.54 | $878 | 2,926 |
| 2023-11-06 | Finley John David CEO, CFO, Director | Option exercise | +3,475 | 47,781 | ||
| 2023-11-06 | Finley John David CEO, CFO, Director | Option exercise · Restricted Stock Units | −3,475 | 31,275 | ||
| 2023-11-06 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +4,556 | 4,556 | ||
| 2023-11-06 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise · Restricted Stock Units | −4,556 | 50,144 | ||
| 2023-10-04 | Finley John David CEO, CFO, Director | Shares withheld for taxes | −397 | $0.55 | $218 | 44,306 |
| 2023-10-03 | Finley John David CEO, CFO, Director | Option exercise | +1,309 | 44,703 | ||
| 2023-10-03 | Finley John David CEO, CFO, Director | Option exercise · Restricted Stock Units | −1,309 | 1,309 |
Page 9 of 12 · 233 trades